연구성과로 돌아가기

2021 연구자 정보 (94 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Anh Duc Tran
(Tran, AD) ⓘ 		Hue Cent Hosp, Stroke Ctr, Hue, Vietnam ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Antsov, Katrin
(Antsov, K) ⓘ 		Parnu Hosp, Internal Med Clin, Parnu, Estonia ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Arabambi, Babawale
(Arabambi, B) ⓘ 		Lagos State Univ Teaching Hosp, Dept Med, Neurol Unit, Lagos, Nigeria ⓘ GSM-7498-2022
Arabambi, Babawale ⓘ 		0000-0002-7591-9404
Arabambi, Babawale ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Aref, Hany M.
(Aref, HM) ⓘ 		Ain Shams Univ Specialized Hosp, Cairo, Egypt ⓘ AAW-3366-2020
Aref, Hany ⓘ 		0000-0003-1497-7915
Aref, Hany ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Aziz, Zariah Abdul
(Aziz, ZA) ⓘ 		Sultanah Nur Zahirah, Kuala Terengganu, Malaysia ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Bach, Ivo
(Bach, I) ⓘ 		Rutgers, New Jersey Med Sch, Univ Hosp Newark, Neurol, Newark, NJ USA ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Badruddin, Aamir
(Badruddin, A) ⓘ 		Community Healthcare Syst, Munster, IN USA ⓘ D-4773-2015
Badruddin, B. ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Bae, Eun Jung
(Bae, EJ) ⓘ 		제1저자 Gwangju Inst Sci & Technol, Dept Chem, Gwangju 61005, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ hailkim@kaist.edu;jhahn@gist.ac.kr; ⓘ
Bae, Myung Ae
(Bae, MA) ⓘ 		Korea Res Inst Chem Technol, Bio & Drug Discovery Div, Daejeon 34114, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ hailkim@kaist.edu;jhahn@gist.ac.kr; ⓘ
Baek, Jang-Hyun
(Baek, JH) ⓘ 		Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Neurol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Bai, Fanghui
(Bai, FH) ⓘ 		Nanyang Cent Hosp, Dept Neurol, Nanyang, Henan, Peoples R China ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Balaguera, Oscar
(Balaguera, O) ⓘ 		Hosp Agudos Dr Ignacio Privano, Buenos Aires, DF, Argentina ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Bandini, Fabio
(Bandini, F) ⓘ 		Osped San Paolo, Dept Neurol, Savona, Italy ⓘ AAE-3431-2020
Bandini, Fabio ⓘ 		0000-0002-1104-459X
Bandini, Fabio ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Banerjee, Soma
(Banerjee, S) ⓘ 		Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Stroke Med, London, England ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Global Impact of COVID-19 on Stroke Care and IV Thrombolysis ⓘ SCIE ⓘ 4.0 CLINICAL NEUROLOGY ⓘ thanh.nguyen@bmc.org; ⓘ
Bang, Oh Young
(Bang, OY) ⓘ 		교신저자 Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Seoul, South Korea
Samsung Med Ctr, Translat & Stem Cell Res Lab Stroke, Seoul, South Korea
Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
Samsung Med Ctr, Stroke Ctr, 81 Irwon Ro, Seoul 06351, South Korea
Samsung Med Ctr, Dept Neurol, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea
Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea
Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke
[JCR상위 25.0] Interpretable machine learning for early neurological deterioration prediction in atrial fibrillation-related stroke
[JCR상위 41.3] Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
[JCR상위 71.2] CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation A nationwide multicenter registry study
[JCR상위 56.0] Pre-Admission CHADS2 and CHA2DS2-VASc Scores on Early Neurological Worsening
[JCR상위 8.7] Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke
[JCR상위 6.4] Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation
[JCR상위 71.9] Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study ⓘ 		SCIE ⓘ 4.0 CLINICAL NEUROLOGY
MULTIDISCIPLINARY SCIENCES
CLINICAL NEUROLOGY;NEUROSCIENCES
MEDICINE, GENERAL & INTERNAL
CLINICAL NEUROLOGY;PERIPHERAL VASCULAR DISEASE ⓘ 		ohyoung.bang@samsung.com;
mcastenosis@gmail.com;jinmanjung@gmail.com;dr.jinmanjung@gmail.com;
shheo73@khu.ac.kr;mcastenosis@gmail.com;
mcastenosis@gmail.com;
ckkim7@korea.ac.kr;mcastenosis@gmail.com;
yangha.hwang@gmail.com;mcastenosis@gmail.com;
jhpark619@hanyang.ac.kr;mcastenosis@gmail.com;
nrhks455@gmail.com;sukwon@amc.seoul.kr; ⓘ
페이지 이동: